Legend Biotech Corp (LEGN) stock is lower by -29.70% since Friday, June 5, 2020 when Legend Biotech Corp began trading, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives LEGN stock a score of 34 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 3. LEGN's rank also includes a short-term technical score of 12. The fundamental score for LEGN is 88. In addition to the average rating from Wall Street analysts, LEGN stock has a mean target price of 50.666. This means analysts expect the stock to climb 94.79% over the next 12 months.
What's Happening with LEGN Stock Today
Legend Biotech Corp (LEGN) stock is higher by 0.79% while the S&P 500 is higher by 0.41% as of 3:01 PM on Friday, Apr 16. LEGN is higher by $0.20 from the previous closing price of $25.80 on volume of 141,842 shares. Over the past year the S&P 500 has gained 31.11% while LEGN is lower by -29.70%. LEGN lost -$2.28 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Legend Biotech Corp (LEGN) Stock.
